Difesa Capital Management, LP Xenon Pharmaceuticals Inc. Transaction History

Difesa Capital Management, LP

  • $0
  • Q4 2023

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$30.79 - $39.82 $754,355 - $975,590
24,500 New
24,500 $884,000
Q1 2022

May 16, 2022
SELL
$25.09 - $33.13 $250,900 - $331,300
-10,000 Closed
0 $0
Q4 2021

Feb 10, 2022
BUY
$15.6 - $35.4 $156,000 - $354,000
10,000 New
10,000 $312,000

Others Institutions Holding XENE

# of Institutions
212
Shares Held
70.2M
Call Options Held
88.3K
Put Options Held
28.8K
View Full List

About Xenon Pharmaceuticals Inc.

XENE Quotes by TradingView
  • Ticker XENE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,263,500
  • Market Cap $2.42B
  • Description
  • Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...
More about XENE
Track This Portfolio

Track Difesa Capital Management, LP Portfolio

Follow Difesa Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Difesa Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Difesa Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email